Cargando…

Novel Therapies and Approaches to Relapsed/Refractory HL Beyond Chemotherapy

Although Hodgkin lymphoma (HL) is highly curable with first-line therapy, relapses occur in approximately 10–20% of patients with early stage disease and 30–40% of patients with advanced stage disease. The standard approach for relapsed or refractory disease is salvage therapy, followed by consolida...

Descripción completa

Detalles Bibliográficos
Autores principales: Mina, Alain Antoine, Vakkalagadda, Chetan, Pro, Barbara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6468730/
https://www.ncbi.nlm.nih.gov/pubmed/30934568
http://dx.doi.org/10.3390/cancers11030421